- In November 2021, Aytu BioPharma, a US-based pharmaceutical business, reported that the U.S. Patent and Trademark Office had granted it a U.S. patent for the Healight ultraviolet-A light-based pulmonary catheter.
- In November 2021, The UK-based The Flume Catheter Company Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted it permission to market the FLUME catheter in the U.S.
Frequently Asked Questions
Rising Demand for Minimally Invasive Procedures in Cardiovascular Treatment, is emerging as a pivotal trend driving the global Cardiac Catheters market.
The major factors driving the growth of the Cardiac Catheters market are Increasing prevalence of chronic illnesses and Rise in cardiac disorders
The primary challenges include High cost and High risk of infections through catheters
The electrophysiology catheters segment is expected to dominate the global cardiac catheters market, holding a significant market share in 2025.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2025 to 2032 due to the rising economies and increasing pool of cardiac disorders patients. Moreover government’s initiative towards improving healthcare infrastructure will also boost market.
